Emergent BioSolutions Inc (NYSE:EBS)

30.51
Delayed Data
As of Aug 12
 +0.62 / +2.07%
Today’s Change
26.85
Today|||52-Week Range
65.09
-29.81%
Year-to-Date
Why Emergent BioSolutions Stock Is Sinking Today
Aug 02 / MotleyFool.com - Paid Partner Content
Emergent BioSolutions (EBS) Q2 2022 Earnings Call Transcript
Aug 01 / MotleyFool.com - Paid Partner Content
Emergent's (EBS) Q2 Earnings and Revenues Miss Estimates
Aug 02 / Zacks.com - Paid Partner Content
Emergent Biosolutions (EBS) Reports Q2 Loss, Misses Revenue Estimates
Aug 01 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close29.89
Today’s open30.51
Day’s range29.61 - 30.87
Volume1,133,343
Average volume (3 months)721,123
Market cap$1.5B
Data as of 4:00pm ET, 08/12/2022

Growth & Valuation

Earnings growth (last year)-25.45%
Earnings growth (this year)-98.53%
Earnings growth (next 5 years)+34.00%
Revenue growth (last year)+15.26%
P/E ratio17.8
Price/Sales1.31
Price/Book0.97

Competitors

 Today’s
change
Today’s
% change
PRTAProthena Corporation...+0.88+2.81%
RGNXRegenxbio Inc+0.23+0.69%
NGMNGM Biopharmaceutica...+0.10+0.59%
----
Data as of 4:00pm ET, 08/12/2022

Financials

Next reporting dateNovember 3, 2022
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$1.8B
Annual profit (last year)$230.9M
Net profit margin12.88%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Gaithersburg, Maryland

Forecasts